None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals presenting symptoms of continuous or repetitive fatigue of an unknown cause for at least 6 months. 2. Individuals without any abnormal findings in their blood pressure, general blood test (Hb, Hct, WBC, glucose), biochemical test (AST, ALT, Creatinine), electrolyte test (Na, K, Cl), thyroid function test (TSH: Thyroid Stimulating Hormone, FT_4: Free Thyroxine_4), pregnancy test (for fertile women), chest X-ray, and ECG; However, the criteria for abnormal findings were as follows: blood pressure was measured twice and averaged in a sitting position, with at least 2-minute intervals after resting at least for 5 minutes; systolic blood pressure of 160 mmHg and over or diastolic blood pressure of 100 mmHg and over; adult male Hb 13g/dL or less, Hct 38% or less, adult female(non-pregnant) Hb 11.5g/dL or less, Hct 36% or less, WBC 10,000/mm3 or over, random plasma glucose 200mg/dL or over, AST•ALT 100 IU/L or over, respectively, creatinine 1.5mg/dL or over, Na 135mmol/L or less or 145mmol/L or over, K 3.5mmol/L or less or 5.5mmol/L or over, Cl 97 mmol/L or less or 110 mmol/L or over, TSH 0.35mIU/mL or less or 5.50mIU/mL or over, FT4 0.89ng/dL or less or 1.76ng/dL or over, positive urinary hCG, tuberculosis lesions in the chest X-ray except inactive tuberculosis, arrhythmia in the ECG that needs treatment, heart diseases such as ischemic heart disease or cardiomegaly. 3. Individuals with NRS(Numeric Rating Scale) over 4 in the past week during the visit for screening. 4. Individuals who are clearly informed of the purpose and characteristics of the trial, agree to participate in it, and sign the consent form.
Exclusion criteria
Exclusion criteria: 1. Individuals with the following causes of chronic fatigue in their past or current medical history: a. Organic causes: acute or chronic liver disease (hepatitis, cirrhosis), anemia, tuberculosis, chronic lung disease, cardiovascular disease (heart failure, hypertension), endocrinology/metabolic disorders (diabetes, hyperthyroidism or hypothyroidism, severe obesity with BMI over 45), autoimmune disease (rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis), malignant tumors, and infectious diseases. b. Psychosocial causes: depression, anxiety neurosis, recent severe stress, schizophrenia, alcoholism, eating disorders (anorexia, bulimia). 2. Individuals into whose body metal prostheses have been inserted to within 30cm of the electrode attachment spots. 3. Pregnant women, lactating women, or women planning pregnancy. 4. Individuals who are judged unable to maintain a supine position for at least for one hour. 5. Individuals who are unsuitable for acupuncture treatment due to systemic skin disorders or metal allergies. 6. Individuals who are currently participating in another clinical trial. 7. Individuals who have already experienced a hypersensitive reaction after acupuncture treatment. 8. Individuals currently residing in group facilities such as social welfare facilities. 9. Individuals who refuse to sign the consent form. 10. Individuals who are judged by the researchers to be unsuitable to participate in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bio-potential data | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue Severity Scale;Numeric Rating Scale | — |
Countries
Korea, Republic of
Contacts
Korea Institute of Oriental Medicine